Nutraceuticals: What’s that? - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Nutraceuticals: What’s that?

Aug 13, 2001

"An apple a day keeps the doctor away”, as the saying goes. But do you have apples everyday or rather do you remember to have apples on your dining table. Not feasible, right? Why bother now that you have simple pills to pop up instead. That’s exactly what nutraceuticals is all about. Nutraceuticals describes a host of preparations, which are gaining acceptance these days to substitute your ideal diet. The term “nutraceuticals” combines the word “nutrient” with “pharmaceuticals” to describe dietary supplements used for the treatment or prevention of diseases.

Nurtraceuticals are derived from naturally occurring substances that should ideally form part of your daily diet or which have some remedial values. Take for example, broccoli vegetable, which is supposed to protect against cancer. However, consuming broccoli may not be feasible everyday, but a 500 mg tablet of broccoli extract may just do the trick. Grapes are rich in flavonoids, which have anti-oxidant properties. Garlic is beneficial to control cholesterol levels. The list is long. In short, nutraceuticals can be an alternative to the most suitable diet for you.

Nutraceuticals need not come only as tablets. They could be foods and beverages too. The beverage segment is one of the fastest growing sub-segments of the nutraceuticals markets and also has the benefit of being convenient for the addition of nutraceutical ingredients. Beverages could include meal replacement beverages, lifestyle and wellness beverages, medicinal teas and isotonic beverages. In the U.S., the beverage market accounts for $1.17 billion of the nutraceuticals market, valued at approximately $86 billion and growing 10% annually.

It is estimated that more than 100 million people in the U.S. use nutraceuticals. In Japan, about 47% of the population consume these products. The interest in nutraceuticals could be related to a perception that “natural is good”. They are particularly favored for their supposed benefits in chronic disease and in trying to ward off the effects of aging. Optimism regarding their roles in preventing disease may have also contributed to their popularity.

Go to the pharma store in your neighborhood and you will find hosts of medicines claiming to improve your memory skills, body resistance, stamina, delaying your aging process, etc., etc. Take for example, a product from Ajanta Pharma called ‘Carofit’. The product is essentially a carrot extract supplemented with essential vitamins, supposed to be taken only once with your breakfast. The company claims that the product is effective for a range of issues including repairing tissue damage, improving immunity, to reduce environmental pollution effects etc. Convenient, isn’t it?

There is no doubt that the concept of nutraceuticals is catching up in India. However, the key deterrent for the nutraceutical industry growth in India is affordability. The guy on the street is not going to consume a vegetable extract if it costs him many times higher than the vegetable itself.

Equitymaster requests your view! Post a comment on "Nutraceuticals: What’s that?". Click here!

  

More Views on News

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Dec 1, 2021 (Close)

MARKET STATS